中国卒中杂志
中國卒中雜誌
중국졸중잡지
CHINESE JOURNAL OF STROKE
2015年
7期
550-556
,共7页
张宁%杨洋%王铄%李菁晶%王春雪%王拥军
張寧%楊洋%王鑠%李菁晶%王春雪%王擁軍
장저%양양%왕삭%리정정%왕춘설%왕옹군
睡眠%抑郁%患病率%危险因素%前瞻性队列研究
睡眠%抑鬱%患病率%危險因素%前瞻性隊列研究
수면%억욱%환병솔%위험인소%전첨성대렬연구
Sleep%Depression%Incidence%Risk factor%Prospective cohort study
目的:调查缺血性卒中患者发病1年睡眠质量下降发生率及睡眠质量下降的危险因素。方法连续入组住院治疗的急性缺血性卒中患者。收集患者的人口学资料、既往病史、临床指标及影像学资料(急性期病灶部位)。随访患者发病后14 d是否存在卒中后抑郁、抗抑郁药物使用与否、评定美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)、简易精神状态检查量表(Mini Mental State Examination,MMSE)、汉密尔顿抑郁量表(Hamilton Depression Rating Scale,HRSD)和汉密尔顿焦虑量表(Hamilton Anxiety Scale,HAMA);发病1年后随访卒中复发、评定改良Rankin量表(modified Rankin Scale,mRS)、HRSD、HAMA和匹兹堡睡眠质量指数(Pittsburgh Sleep Quality Indexs,PSQI)。以PSQI≥8分为患者存在睡眠质量问题,对可能影响睡眠的因素进行单因素和多因素分析。结果研究期间共入组并完成随访的患者共233例。1年随访时PSQI≥8分,提示存在睡眠质量问题的患者为31例(13.3%)。单因素分析结果显示睡眠质量下降与随访时患者是否服用抗抑郁药物(χ2=3.9657,P=0.0464)、发病14 d内的HRSD评分(Z=1.9712,0.0487)、1年随访时HRSD评分(Z=6.7303, P<0.0001)和HAMA评分有关(Z=6.6807,P<0.0001);多因素分析显示1年随访阶段的HAMA评分[比值比(odds ratio,OR)1.666,95%可信区间(confidence interval,CI)1.309~2.120,P<0.0001]是卒中患者慢性期睡眠质量下降的独立危险因素。结论睡眠障碍在卒中慢性期发生率仍较高,慢性期焦虑水平是睡眠质量下降的独立危险因素。
目的:調查缺血性卒中患者髮病1年睡眠質量下降髮生率及睡眠質量下降的危險因素。方法連續入組住院治療的急性缺血性卒中患者。收集患者的人口學資料、既往病史、臨床指標及影像學資料(急性期病竈部位)。隨訪患者髮病後14 d是否存在卒中後抑鬱、抗抑鬱藥物使用與否、評定美國國立衛生研究院卒中量錶(National Institutes of Health Stroke Scale,NIHSS)、簡易精神狀態檢查量錶(Mini Mental State Examination,MMSE)、漢密爾頓抑鬱量錶(Hamilton Depression Rating Scale,HRSD)和漢密爾頓焦慮量錶(Hamilton Anxiety Scale,HAMA);髮病1年後隨訪卒中複髮、評定改良Rankin量錶(modified Rankin Scale,mRS)、HRSD、HAMA和匹玆堡睡眠質量指數(Pittsburgh Sleep Quality Indexs,PSQI)。以PSQI≥8分為患者存在睡眠質量問題,對可能影響睡眠的因素進行單因素和多因素分析。結果研究期間共入組併完成隨訪的患者共233例。1年隨訪時PSQI≥8分,提示存在睡眠質量問題的患者為31例(13.3%)。單因素分析結果顯示睡眠質量下降與隨訪時患者是否服用抗抑鬱藥物(χ2=3.9657,P=0.0464)、髮病14 d內的HRSD評分(Z=1.9712,0.0487)、1年隨訪時HRSD評分(Z=6.7303, P<0.0001)和HAMA評分有關(Z=6.6807,P<0.0001);多因素分析顯示1年隨訪階段的HAMA評分[比值比(odds ratio,OR)1.666,95%可信區間(confidence interval,CI)1.309~2.120,P<0.0001]是卒中患者慢性期睡眠質量下降的獨立危險因素。結論睡眠障礙在卒中慢性期髮生率仍較高,慢性期焦慮水平是睡眠質量下降的獨立危險因素。
목적:조사결혈성졸중환자발병1년수면질량하강발생솔급수면질량하강적위험인소。방법련속입조주원치료적급성결혈성졸중환자。수집환자적인구학자료、기왕병사、림상지표급영상학자료(급성기병조부위)。수방환자발병후14 d시부존재졸중후억욱、항억욱약물사용여부、평정미국국립위생연구원졸중량표(National Institutes of Health Stroke Scale,NIHSS)、간역정신상태검사량표(Mini Mental State Examination,MMSE)、한밀이돈억욱량표(Hamilton Depression Rating Scale,HRSD)화한밀이돈초필량표(Hamilton Anxiety Scale,HAMA);발병1년후수방졸중복발、평정개량Rankin량표(modified Rankin Scale,mRS)、HRSD、HAMA화필자보수면질량지수(Pittsburgh Sleep Quality Indexs,PSQI)。이PSQI≥8분위환자존재수면질량문제,대가능영향수면적인소진행단인소화다인소분석。결과연구기간공입조병완성수방적환자공233례。1년수방시PSQI≥8분,제시존재수면질량문제적환자위31례(13.3%)。단인소분석결과현시수면질량하강여수방시환자시부복용항억욱약물(χ2=3.9657,P=0.0464)、발병14 d내적HRSD평분(Z=1.9712,0.0487)、1년수방시HRSD평분(Z=6.7303, P<0.0001)화HAMA평분유관(Z=6.6807,P<0.0001);다인소분석현시1년수방계단적HAMA평분[비치비(odds ratio,OR)1.666,95%가신구간(confidence interval,CI)1.309~2.120,P<0.0001]시졸중환자만성기수면질량하강적독립위험인소。결론수면장애재졸중만성기발생솔잉교고,만성기초필수평시수면질량하강적독립위험인소。
Objective To investigate the sleep quality of stroke patients in 1-year follow-up, with an attempt to understand the prevalence and risk factors of sleep quality. Methods Eligible inpatients with acute ischemic cerebrovascular diseases were treated in the stroke unit of the Department of Neurology. Demographic data, disease history, associated clinical indicators, and imaging data (sites of acute lesions) were collected. Two follow-up visits were carried out for all the enrolled patients: visit 1 (including National Institutes of Health Stroke Scale [NIHSS], Mini Mental State Examination [MMSE], Hamilton Depression Rating Scale [HRSD] and Hamilton Anxiety Scale [HAMA]), 14 days after onset; and visit 2 (including modiifed Rankin Scale [mRS], HRSD, HAMA and Pittsburgh Sleep Quality Indexs [PSQI]), 1 year after onset. A PSQI score8 was considered sleep disorder. Data were analyzed using SAS 9.2 software. Results A total of 233 cases of stroke patients completed the follow-up 1 year from the onset. The incidence of sleep disorders was 13.3% (39 cases) at one-year follow up. Univariate analysis showed that the sleep disorders were correlated with antidepressant medication at visits (χ2=3.9657, P=0.0464), HRSD scores within 14 days after onset (Z=1.9712,P=0.0487), HRSD scores at visit 2 (Z=6.7303,P<0.0001), and HAMA scores (Z=6.6807,P<0.0001). Multivariate analysis showed that the HAMA scores at visit 2 was an independent risk factor for sleep disorders in the chronic stage of stroke (odds ratio [OR] 1.666, 95% conifdence interval [CI] 1.309~2.120,P<0.0001). Conclusion The incidence of sleep disorder can be high at the chronic stages of stroke. The level of depression at the chronic stage (HAMA score) is the only independent risk factor for sleep disorders.